The Gross Law Firm issues the following notice to shareholders of RCI Hospitality Holdings, Inc. (NASDAQ: RICK). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of RICK during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: […]

The Gross Law Firm issues the following notice to shareholders of KBR, Inc. (NYSE: KBR). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of KBR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: KBR, Inc.

The Gross Law Firm issues the following notice to shareholders of Cytokinetics, Incorporated (NASDAQ: CYTK). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of CYTK during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Cytokinetics Loss

The Gross Law Firm issues the following notice to shareholders of Fluor Corporation (NYSE: FLR). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of FLR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Fluor Corporation

The Gross Law Firm issues the following notice to shareholders of V.F. Corporation (NYSE: VFC). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of VFC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: V.F. Corporation

The Gross Law Firm issues the following notice to shareholders of Fly-E Group, Inc. (NASDAQ: FLYE). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of FLYE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Fly-E

The Gross Law Firm issues the following notice to shareholders of Lantheus Holdings, Inc. (NASDAQ: LNTH). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of LNTH during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Lantheus

The Gross Law Firm issues the following notice to shareholders of Savara Inc. (NASDAQ: SVRA). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of SVRA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Savara Inc.

Integration boosts Grid AI’s deployment capacity as AI data-center power demand approaches 50 GW, growing by over 165% through 2030i BOCA RATON, FL / ACCESS Newswire / November 6, 2025 / Entero Therapeutics, Inc. (NASDAQ:ENTO) ("ENTO" or the "Company"), the parent company of Grid AI, announced today the signing of a Letter of Intent to

(NASDAQ:DWTX), – Enrollment to date of 100 patients, with 80 patients completing treatment in the ongoing Halneuron(R) Phase 2b trial, prespecified interim analysis remains on track for Q4 2025 release – – Secured exclusive worldwide, royalty free license to develop and commercialize SP16 as a synergistic and complementary pipeline treatment for cancer-related pain in an